Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 24 09 2021
accepted: 14 01 2022
pubmed: 21 4 2022
medline: 28 9 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

The World Health Organization (WHO) recommends adults complete 150-300 min per week of moderate physical activity or 75-150 min of vigorous physical activity or an equivalent combination of both, to optimize health. To explore the factors associated with adequate MVPA in stabilized outpatients with schizophrenia. 425 stabilized outpatients were recruited in the national FACE-SZ cohort between 2015 and 2018 were evaluated with the International Physical Activity Questionnaire and a 1-day long standardized battery. We explored in multivariate analyses the clinical and pharmacological factors associated with MVPA (model 1) and the biological factors and patient-reported outcomes (model 2). Overall, only 86 (20.2%) of the 425 participants achieved the recommended MVPA threshold. In model 1, the adequate MVPA group was associated with younger age, mood stabilizers prescription and adherence to treatment, independent of sex, positive and depressive symptoms, first-generation antipsychotics prescription, anxiolytic medication, and akathisia. In model 2, adequate MVPA was associated with better glycemic and lipidic profile and better physical and psychological well-being, self-esteem, sentimental life, and resilience independently of age, sex, and current psychotic severity. The expert centers recommend the importance of promoting promote effective MVPA programs for stabilized patients with schizophrenia. Interventions studies suggest that MVPA may be a useful strategy to maximize physical and psychological well-being and self-esteem and potentially to prevent or manage metabolic disturbances.

Identifiants

pubmed: 35441901
doi: 10.1007/s00406-022-01384-x
pii: 10.1007/s00406-022-01384-x
doi:

Substances chimiques

Anti-Anxiety Agents 0
Antipsychotic Agents 0
Biological Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1273-1282

Investigateurs

M Andre (M)
C Andrieu-Haller (C)
B Aouizerate (B)
F Berna (F)
O Blanc (O)
E Bourguignon (E)
D Capdevielle (D)
I Chereau-Boudet (I)
J Clauss-Kobayashi (J)
N Coulon (N)
R Dassing (R)
J M Dorey (JM)
C Dubertret (C)
A Esselin (A)
G Fond (G)
F Gabayet (F)
M Jarroir (M)
D Lacelle (D)
M Leboyer (M)
S Leignier (S)
P M Llorca (PM)
J Mallet (J)
E Metairie (E)
T Michel (T)
D Misdrahi (D)
C Passerieux (C)
J Petrucci (J)
B Pignon (B)
P Peri (P)
C Portalier (C)
R Rey (R)
C Roman (C)
B Schorr (B)
F Schürhoff (F)
A Szöke (A)
A Tessier (A)
M Urbach (M)
G Wachiche (G)
A Zinetti-Bertschy (A)

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Références

Bull FC, Al-Ansari SS, Biddle S et al (2020) World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med 54:1451–1462. https://doi.org/10.1136/bjsports-2020-102955
doi: 10.1136/bjsports-2020-102955 pubmed: 33239350
Stubbs B, Williams J, Gaughran F, Craig T (2016) How sedentary are people with psychosis? A systematic review and meta-analysis. Schizophr Res 171:103–109. https://doi.org/10.1016/j.schres.2016.01.034
doi: 10.1016/j.schres.2016.01.034 pubmed: 26805414
Scheewe TW, Jörg F, Takken T et al (2019) Low physical activity and cardiorespiratory fitness in people with schizophrenia: a comparison with matched healthy controls and associations with mental and physical health. Front Psychiatry 10:87. https://doi.org/10.3389/fpsyt.2019.00087
doi: 10.3389/fpsyt.2019.00087 pubmed: 30873051 pmcid: 6404550
Stubbs B, Firth J, Berry A et al (2016) How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression. Schizophr Res 176:431–440. https://doi.org/10.1016/j.schres.2016.05.017
doi: 10.1016/j.schres.2016.05.017 pubmed: 27261419
Stubbs B, Vancampfort D, Hallgren M et al (2018) EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH). Eur Psychiatry 54:124–144. https://doi.org/10.1016/j.eurpsy.2018.07.004
doi: 10.1016/j.eurpsy.2018.07.004 pubmed: 30257806
Vancampfort D, Rosenbaum S, Ward PB, Stubbs B (2015) Exercise improves cardiorespiratory fitness in people with schizophrenia: a systematic review and meta-analysis. Schizophr Res 169:453–457. https://doi.org/10.1016/j.schres.2015.09.029
doi: 10.1016/j.schres.2015.09.029 pubmed: 26475214
Pasquereau A, Andler R, Arwidson P, Nguyen-Thanh V (2020) Consommation de tabac parmi les adultes: bilan de cinq années de programme national contre le tabagisme, 2014–2019. Bull Epidémiol Hebd 14:273–281
Vancampfort D, Probst M, Scheewe T et al (2013) Relationships between physical fitness, physical activity, smoking and metabolic and mental health parameters in people with schizophrenia. Psychiatry Res 207:25–32. https://doi.org/10.1016/j.psychres.2012.09.026
doi: 10.1016/j.psychres.2012.09.026 pubmed: 23051886
Bobes J, Arango C, Garcia-Garcia M, Rejas J (2010) Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 119:101–109. https://doi.org/10.1016/j.schres.2010.02.1030
doi: 10.1016/j.schres.2010.02.1030 pubmed: 20219322
Vancampfort D, Probst M, Sweers K et al (2011) Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand 123:423–430. https://doi.org/10.1111/j.1600-0447.2010.01666.x
doi: 10.1111/j.1600-0447.2010.01666.x pubmed: 21219266
Schoepf D, Uppal H, Potluri R, Heun R (2014) Physical comorbidity and its relevance on mortality in schizophrenia: a naturalistic 12-year follow-up in general hospital admissions. Eur Arch Psychiatry Clin Neurosci 264:3–28. https://doi.org/10.1007/s00406-013-0436-x
doi: 10.1007/s00406-013-0436-x pubmed: 23942824
Vancampfort D, Stubbs B, Mitchell AJ et al (2015) Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14:339–347. https://doi.org/10.1002/wps.20252
doi: 10.1002/wps.20252 pubmed: 26407790 pmcid: 4592657
Bartels SJ, Pratt SI, Aschbrenner KA et al (2015) Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry 172:344–352. https://doi.org/10.1176/appi.ajp.2014.14030357
doi: 10.1176/appi.ajp.2014.14030357 pubmed: 25827032
Bartels SJ, Pratt SI, Aschbrenner KA et al (2013) Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv 64:729–736. https://doi.org/10.1176/appi.ps.003622012
doi: 10.1176/appi.ps.003622012 pubmed: 23677386 pmcid: 5662189
Daumit GL, Dickerson FB, Wang N-Y et al (2013) A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med 368:1594–1602. https://doi.org/10.1056/NEJMoa1214530
doi: 10.1056/NEJMoa1214530 pubmed: 23517118 pmcid: 3743095
Erickson ZD, Mena SJ, Pierre JM et al (2016) Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial. J Clin Psychiatry 77:e183-189. https://doi.org/10.4088/JCP.14m09552
doi: 10.4088/JCP.14m09552 pubmed: 26930534
Brobakken MF, Nygård M, Güzey IC et al (2019) Aerobic interval training in standard treatment of out-patients with schizophrenia: a randomized controlled trial. Acta Psychiatr Scand 140:498–507. https://doi.org/10.1111/acps.13105
doi: 10.1111/acps.13105 pubmed: 31565796
Poulin M-J, Chaput J-P, Simard V et al (2007) Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry 41:980–989. https://doi.org/10.1080/00048670701689428
doi: 10.1080/00048670701689428 pubmed: 17999270
Lee EE, Hong S, Martin AS et al (2017) Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables. Am J Geriatr Psychiatry 25:50–61. https://doi.org/10.1016/j.jagp.2016.09.009
doi: 10.1016/j.jagp.2016.09.009 pubmed: 27840055
North HF, Bruggemann J, Cropley V et al (2021) Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci 271:595–607. https://doi.org/10.1007/s00406-021-01237-z
doi: 10.1007/s00406-021-01237-z pubmed: 33760971
Tsai S-Y, Sajatovic M, Hsu J-L et al (2020) Body mass index, residual psychotic symptoms, and inflammation associated with brain volume reduction in older patients with schizophrenia. Int J Geriatr Psychiatry 35:728–736. https://doi.org/10.1002/gps.5291
doi: 10.1002/gps.5291 pubmed: 32128879
Hayashino Y, Jackson JL, Hirata T et al (2014) Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism 63:431–440. https://doi.org/10.1016/j.metabol.2013.08.018
doi: 10.1016/j.metabol.2013.08.018 pubmed: 24355625
Alizaei Yousefabadi H, Niyazi A, Alaee S et al (2021) Anti-inflammatory effects of exercise on metabolic syndrome patients: a systematic review and meta-analysis. Biol Res Nurs 23:280–292. https://doi.org/10.1177/1099800420958068
doi: 10.1177/1099800420958068 pubmed: 32938197
Martland R, Mondelli V, Gaughran F, Stubbs B (2020) Can high-intensity interval training improve physical and mental health outcomes? A meta-review of 33 systematic reviews across the lifespan. J Sports Sci 38:430–469. https://doi.org/10.1080/02640414.2019.1706829
doi: 10.1080/02640414.2019.1706829 pubmed: 31889469
Stubbs B, Gardner-Sood P, Smith S et al (2015) Sedentary behaviour is associated with elevated C-reactive protein levels in people with psychosis. Schizophr Res 168:461–464. https://doi.org/10.1016/j.schres.2015.07.003
doi: 10.1016/j.schres.2015.07.003 pubmed: 26189077
Schürhoff F, Fond G, Berna F et al (2019) The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): review and recommendations for clinical practice. Encephale 45:9–14. https://doi.org/10.1016/j.encep.2018.07.007
doi: 10.1016/j.encep.2018.07.007 pubmed: 30327207
Fond G, Godin O, Schürhoff F et al (2020) Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort. Prog Neuropsychopharmacol Biol Psychiatry 101:109927. https://doi.org/10.1016/j.pnpbp.2020.109927
doi: 10.1016/j.pnpbp.2020.109927 pubmed: 32173456
Schürhoff F, Fond G, Berna F et al (2015) A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap. Eur Psychiatry. https://doi.org/10.1016/j.eurpsy.2015.05.004
doi: 10.1016/j.eurpsy.2015.05.004 pubmed: 26072427
Appelberg B, Tuisku K, Joffe G (2004) Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine. Eur Psychiatry 19:516–518
doi: 10.1016/j.eurpsy.2004.06.035
First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition (SCID-I/P). Biometrics research. New York State Psychiatric Institute, New York
Craig CL, Marshall AL, Sjöström M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395. https://doi.org/10.1249/01.MSS.0000078924.61453.FB
doi: 10.1249/01.MSS.0000078924.61453.FB pubmed: 12900694
World Health Organization: Geneva (2010) Global recommendations on physical activity for health. World Health Organization, Geneva
Wallwork RS, Fortgang R, Hashimoto R et al (2012) Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia. Schizophr Res 137:246–250. https://doi.org/10.1016/j.schres.2012.01.031
doi: 10.1016/j.schres.2012.01.031 pubmed: 22356801 pmcid: 3351536
Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435. https://doi.org/10.1192/bjp.133.5.429
doi: 10.1192/bjp.133.5.429 pubmed: 728692
Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213. https://doi.org/10.1016/0165-1781(89)90047-4
doi: 10.1016/0165-1781(89)90047-4 pubmed: 2748771
Leucht S, Samara M, Heres S et al (2014) Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr Bull 40:314–326. https://doi.org/10.1093/schbul/sbu001
doi: 10.1093/schbul/sbu001 pubmed: 24493852 pmcid: 3932104
Misdrahi D, Tessier A, Swendsen J et al (2016) Determination of adherence profiles in schizophrenia using self-reported adherence: results from the FACE-SZ dataset. J Clin Psychiatry 77:e1130–e1136. https://doi.org/10.4088/JCP.15m10115
doi: 10.4088/JCP.15m10115 pubmed: 27780318
Fond G, Boyer L, Boucekine M et al (2017) Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset. Schizophr Res 182:84–89. https://doi.org/10.1016/j.schres.2016.10.023
doi: 10.1016/j.schres.2016.10.023 pubmed: 27789187
Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11–19. https://doi.org/10.1111/j.1600-0447.1970.tb02066.x
doi: 10.1111/j.1600-0447.1970.tb02066.x pubmed: 4917967
Barnes TR (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154:672–676. https://doi.org/10.1192/bjp.154.5.672
doi: 10.1192/bjp.154.5.672 pubmed: 2574607
Boyer L, Simeoni M-C, Loundou A et al (2010) The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res 121:241–250. https://doi.org/10.1016/j.schres.2010.05.019
doi: 10.1016/j.schres.2010.05.019 pubmed: 20541912
Morosini PL, Magliano L, Brambilla L et al (2000) Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101:323–329
doi: 10.1111/j.1600-0447.2000.tb10933.x
Clayton AH, McGarvey EL, Clavet GJ (1997) The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull 33:731–745
pubmed: 9493486
Fond G, Godin O, Dumontaud M et al (2019) Sexual dysfunctions are associated with major depression, chronic inflammation and anticholinergic consumption in the real-world schizophrenia FACE-SZ national cohort. Prog Neuropsychopharmacol Biol Psychiatry 94:109654. https://doi.org/10.1016/j.pnpbp.2019.109654
doi: 10.1016/j.pnpbp.2019.109654 pubmed: 31125587
Battaglia G, Alesi M, Inguglia M et al (2013) Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia. Neuropsychiatr Dis Treat 9:595–603. https://doi.org/10.2147/NDT.S44066
doi: 10.2147/NDT.S44066 pubmed: 23662058 pmcid: 3647379
Dauwan M, Begemann MJH, Heringa SM, Sommer IE (2016) Exercise improves clinical symptoms, quality of life, global functioning, and depression in schizophrenia: a systematic review and meta-analysis. Schizophr Bull 42:588–599. https://doi.org/10.1093/schbul/sbv164
doi: 10.1093/schbul/sbv164 pubmed: 26547223
Fernández-Abascal B, Suárez-Pinilla P, Cobo-Corrales C et al (2021) In- and outpatient lifestyle interventions on diet and exercise and their effect on physical and psychological health: a systematic review and meta-analysis of randomised controlled trials in patients with schizophrenia spectrum disorders and first episode of psychosis. Neurosci Biobehav Rev 125:535–568. https://doi.org/10.1016/j.neubiorev.2021.01.005
doi: 10.1016/j.neubiorev.2021.01.005 pubmed: 33503476
Verdot C, Salanave B, Deschamps V (2020) Activité physique et sédentarité dans la population française. Situation en 2014–2016 et évolution depuis 2006–2007. Bull Epidémiol Hebd 15:296–304
Guthold R, Stevens GA, Riley LM, Bull FC (2018) Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants. Lancet Glob Health 6:e1077–e1086. https://doi.org/10.1016/S2214-109X(18)30357-7
doi: 10.1016/S2214-109X(18)30357-7 pubmed: 30193830
Roberts V, Maddison R, Simpson C et al (2012) The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect, and smoking behaviour: systematic review update and meta-analysis. Psychopharmacology 222:1–15. https://doi.org/10.1007/s00213-012-2731-z
doi: 10.1007/s00213-012-2731-z pubmed: 22585034
Taylor AH, Ussher MH, Faulkner G (2007) The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect and smoking behaviour: a systematic review. Addiction 102:534–543. https://doi.org/10.1111/j.1360-0443.2006.01739.x
doi: 10.1111/j.1360-0443.2006.01739.x pubmed: 17286639
Espernberger KR, Fini NA, Peiris CL (2021) Personal and social factors that influence physical activity levels in community-dwelling stroke survivors: a systematic review of qualitative literature. Clin Rehabil 35:1044–1055. https://doi.org/10.1177/0269215521993690
doi: 10.1177/0269215521993690 pubmed: 33586479
Firth J, Cotter J, Elliott R et al (2015) A systematic review and meta-analysis of exercise interventions in schizophrenia patients. Psychol Med 45:1343–1361. https://doi.org/10.1017/S0033291714003110
doi: 10.1017/S0033291714003110 pubmed: 25650668
Martin H, Beard S, Clissold N et al (2017) Combined aerobic and resistance exercise interventions for individuals with schizophrenia: a systematic review. Ment Health Phys Act 12:147–155. https://doi.org/10.1016/j.mhpa.2017.04.003
doi: 10.1016/j.mhpa.2017.04.003
Keller-Varady K, Varady PA, Röh A et al (2018) A systematic review of trials investigating strength training in schizophrenia spectrum disorders. Schizophr Res 192:64–68. https://doi.org/10.1016/j.schres.2017.06.008
doi: 10.1016/j.schres.2017.06.008 pubmed: 28602648
Vancampfort D, Rosenbaum S, Schuch FB et al (2016) Prevalence and predictors of treatment dropout from physical activity interventions in schizophrenia: a meta-analysis. Gen Hosp Psychiatry 39:15–23. https://doi.org/10.1016/j.genhosppsych.2015.11.008
doi: 10.1016/j.genhosppsych.2015.11.008 pubmed: 26719106
Bobes J, Alegría AA, Saiz-Gonzalez MD et al (2011) Change in psychiatrists’ attitudes towards the physical health care of patients with schizophrenia coinciding with the dissemination of the consensus on physical health in patients with schizophrenia. Eur Psychiatry 26:305–312. https://doi.org/10.1016/j.eurpsy.2010.04.004
doi: 10.1016/j.eurpsy.2010.04.004 pubmed: 20541373
Costa TB, Neri AL (2019) Associated factors with physical activity and social activity in a sample of Brazilian older adults: data from the FIBRA Study. Rev Bras Epidemiol 22:e190022. https://doi.org/10.1590/1980-549720190022
doi: 10.1590/1980-549720190022 pubmed: 30942329
Eichinger M, Titze S, Haditsch B et al (2015) How are physical activity behaviors and cardiovascular risk factors associated with characteristics of the built and social residential environment? PLoS ONE 10:e0126010. https://doi.org/10.1371/journal.pone.0126010
doi: 10.1371/journal.pone.0126010 pubmed: 26035294 pmcid: 4452766
Flannery C, Dahly D, Byrne M et al (2019) Social, biological, behavioural and psychological factors related to physical activity during early pregnancy in the Screening for Pregnancy Endpoints (Cork, Ireland) cohort study. BMJ Open 9:e025003. https://doi.org/10.1136/bmjopen-2018-025003
doi: 10.1136/bmjopen-2018-025003 pubmed: 31227527 pmcid: 6596951
Morris KA, Arundell L, Cleland V, Teychenne M (2020) Social ecological factors associated with physical activity and screen time amongst mothers from disadvantaged neighbourhoods over three years. Int J Behav Nutr Phys Act 17:110. https://doi.org/10.1186/s12966-020-01015-5
doi: 10.1186/s12966-020-01015-5 pubmed: 32859233 pmcid: 7456370

Auteurs

Pierre-Louis Sunhary De Verville (PL)

Fondation FondaMental, Créteil, France.
AP-HM, Aix-Marseille Univ, Faculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, 27 Boulevard Jean Moulin, 13005, Marseille, France.

Brendon Stubbs (B)

South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, UK.
Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.

Damien Etchecopar-Etchart (D)

Fondation FondaMental, Créteil, France.
AP-HM, Aix-Marseille Univ, Faculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, 27 Boulevard Jean Moulin, 13005, Marseille, France.

Ophélia Godin (O)

Fondation FondaMental, Créteil, France.
Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux Universitaires "H. Mondor", DMU IMPACT, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, 94010, Creteil, France.

Christelle Andrieu-Haller (C)

Fondation FondaMental, Créteil, France.
AP-HM, Aix-Marseille Univ, Faculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, 27 Boulevard Jean Moulin, 13005, Marseille, France.

Fabrice Berna (F)

Fondation FondaMental, Créteil, France.
Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.

Bruno Aouizerate (B)

Fondation FondaMental, Créteil, France.
Pôle de Psychiatrie Générale Et Universitaire, Centre Hospitalier Charles Perrens, 33076 Université de Bordeaux, CNRS UMR 5287-INCIA, Bordeaux, France.
INRA, NutriNeuro, University of Bordeaux, U1286, 33076, Bordeaux, France.

Delphine Capdevielle (D)

Fondation FondaMental, Créteil, France.
Service Universitaire de Psychiatrie Adulte, Hôpital la Colombière, CHRU Montpellier, IGF, Univ. Montpellier, CNRS, INSERM, Montpellier, France.

Isabelle Chereau (I)

Fondation FondaMental, Créteil, France.
Université Clermont Auvergne, CMP-B, CHU, CNRS, Clermont Auvergne INP, Institut Pascal, 63000, Clermont-Ferrand, France.

Julie Clauss-Kobayashi (J)

Fondation FondaMental, Créteil, France.
Hôpitaux Universitaires de Strasbourg, Université de Strasbourg, INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.

Nathalie Coulon (N)

Fondation FondaMental, Créteil, France.
Centre Référent de Réhabilitation Psychosociale, CH Alpes Isère, Grenoble, France.

Jean-Michel Dorey (JM)

Fondation FondaMental, Créteil, France.
INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, Université Claude Bernard Lyon 1, Equipe PSYR2, Centre Hospitalier Le Vinatier, Pole Est, 95 bd Pinel, BP 30039, 69678, Bron Cedex, France.

Caroline Dubertret (C)

Fondation FondaMental, Créteil, France.
Department of Psychiatry, Université de Paris, AP-HP, Louis Mourier Hospital, Colombes, INSERM UMR 1266, Colombes, France.

Sylvain Leignier (S)

Fondation FondaMental, Créteil, France.
Centre Référent de Réhabilitation Psychosociale, CH Alpes Isère, Grenoble, France.

Jasmina Mallet (J)

Fondation FondaMental, Créteil, France.
Department of Psychiatry, Université de Paris, AP-HP, Louis Mourier Hospital, Colombes, INSERM UMR 1266, Colombes, France.

David Misdrahi (D)

Fondation FondaMental, Créteil, France.
Pôle de Psychiatrie Générale Et Universitaire, Centre Hospitalier Charles Perrens, 33076 Université de Bordeaux, CNRS UMR 5287-INCIA, Bordeaux, France.
CNRS UMR 5287-INCIA, Paris, France.

Catherine Passerieux (C)

Fondation FondaMental, Créteil, France.
Service Universitaire de Psychiatrie d'Adultes et d'Addictologie, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157, Le Chesnay, France.
DisAP-DevPsy-CESP, INSERM UMR1018, Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, 94807, Villejuif,, France.

Baptiste Pignon (B)

Fondation FondaMental, Créteil, France.
Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux Universitaires "H. Mondor", DMU IMPACT, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, 94010, Creteil, France.

Romain Rey (R)

Fondation FondaMental, Créteil, France.
INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, Université Claude Bernard Lyon 1, Equipe PSYR2, Centre Hospitalier Le Vinatier, Pole Est, 95 bd Pinel, BP 30039, 69678, Bron Cedex, France.

Mathieu Urbach (M)

Fondation FondaMental, Créteil, France.
Service Universitaire de Psychiatrie d'Adultes et d'Addictologie, Centre Hospitalier de Versailles, 177 rue de Versailles, 78157, Le Chesnay, France.
DisAP-DevPsy-CESP, INSERM UMR1018, Université Paris-Saclay, Université Versailles Saint-Quentin-En-Yvelines, 94807, Villejuif,, France.

Pierre-Michel Llorca (PM)

Fondation FondaMental, Créteil, France.
Université Clermont Auvergne, CMP-B, CHU, CNRS, Clermont Auvergne INP, Institut Pascal, 63000, Clermont-Ferrand, France.

Franck Schürhoff (F)

Fondation FondaMental, Créteil, France.
Université Paris Est Creteil (UPEC), AP-HP, Hôpitaux Universitaires "H. Mondor", DMU IMPACT, INSERM, IMRB, Translational Neuropsychiatry, Fondation FondaMental, 94010, Creteil, France.

Christophe Lançon (C)

Fondation FondaMental, Créteil, France.
AP-HM, Aix-Marseille Univ, Faculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, 27 Boulevard Jean Moulin, 13005, Marseille, France.

Laurent Boyer (L)

Fondation FondaMental, Créteil, France.
AP-HM, Aix-Marseille Univ, Faculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, 27 Boulevard Jean Moulin, 13005, Marseille, France.

Guillaume Fond (G)

Fondation FondaMental, Créteil, France. guillaume.fond@gmail.com.
AP-HM, Aix-Marseille Univ, Faculté de Médecine-Secteur Timone, EA 3279: CEReSS-Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, 27 Boulevard Jean Moulin, 13005, Marseille, France. guillaume.fond@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH